Japanese firm Mitsubishi Tanabe stops commercialisation of COVID-19 vaccine

Japan-based Mitsubishi Chemical Group has decided to cease all of its operations at Medicago Inc., a Canadian subs...

February 6, 2023 | Monday | News
Invivoscribe appoints Masato Sasaki as General Manager of LabPMM, GK (Japan)

US-based firm Invivoscribe has announced the appointment of Masato Sasaki as General Manager of LabPMM GK, its refe...

February 2, 2023 | Thursday | News
Japanese pharma firm Shionogi launches anti-bacterial drug in Denmark

Japan headquartered pharmaceutical company Shionogi & Co. and its European subsidiary, Shionogi B.V. have announced ...

February 2, 2023 | Thursday | News
Japan-based Daiichi Sankyo announces new President and COO

Daiichi Sankyo Company has announced the appointment of a new President & Chief Operating Officer (COO) effect...

February 1, 2023 | Wednesday | News
Japan's Ono Pharma acquires multiple oncology programmes from US-based KSQ Therapeutics

Japan-headquartered Ono Pharmaceutical has entered an agreement with US-based KSQ Therapeutics, a clinical-stage biotech...

January 30, 2023 | Monday | News
Shimadzu opens door to biomolecular imaging with new compact MALDI-TOF solution

Japan-headquartered Shimadzu Corporation has announced the release of the world’s smallest MALDI-TOF imaging solut...

January 26, 2023 | Thursday | News
Aculys Pharma and Four H initiate research collaboration using wearable devices to study sleep disorders in Japan

Aculys Pharma, Inc., a company focused on the development and commercialisation of new innovative drugs in the fields of...

January 25, 2023 | Wednesday | News
Sandoz to acquire rights of antifungal agent Mycamine from Japanese firm Astellas

Japan-headquartered Astellas Pharma has entered into an Asset Purchase Agreement, under which Astellas will transfer the...

January 24, 2023 | Tuesday | News
Takeda inks oncology deal worth $730 M with Hutchmed to improve cancer treatment outside China

Japanese pharmaceutical firm Takeda has entered into an exclusive licensing agreement with Hutchmed (China) for the furt...

January 23, 2023 | Monday | News
Eisai launches subsidiary operations to boost business activities in Israel

Japan headquartered firm Eisai has launched its pharmaceutical sales subsidiary, a fully-fledged operations and bus...

January 19, 2023 | Thursday | News
Japan's Kaneka expands GMP manufacturing capacity for mRNA to Europe

Tokyo Headquarterd Kaneka Corporation is set to increase its GMP manufacturing capacity for mRNA in ...

January 19, 2023 | Thursday | News
Japanese firm Fuji Pharma expands partnership with Alvotech for new biosimilar candidate

European biotech firm Alvotech and Japanese pharmaceutical company Fuji Pharma have decided to expand their existing exc...

January 19, 2023 | Thursday | News
Japan's Astellas Pharma inks $340 M worth deal to advance gene therapy portfolio

US-based Selecta Biosciences, and Japanese firm Astellas Pharma have announced an exclusive licensing and development ag...

January 16, 2023 | Monday | News
Otsuka and Schrödinger announce single-target, drug discovery partnership in neurology

Japanese firm Otsuka Pharmaceutical has announced that the company and its UK-based subsidiary Astex Pharmaceuticals are...

January 13, 2023 | Friday | News
Ajinomoto and Exelixis partner to develop novel antibody-drug conjugates for cancer treatment

Japan-based Ajinomoto has announced a license agreement with US-based firm Exelixis to incorporate AJICAP, Ajinomoto Co....

January 11, 2023 | Wednesday | News
"Crovalimab could potentially become the first global drug originating from Singapore"

Japanese headquartered Chugai Pharmaceutical  has already developed world-class technologies for antibody engineeri...

January 6, 2023 | Friday | Opinion
Moderna buys Japanese startup OriCiro for $85M

Moderna, a US-based biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and OriCiro Genomic...

January 9, 2023 | Monday | News
Kitakyushu General Hospital in Japan advances use of digital laparoscopic platform

Asensus Surgical, a US-based medical device company that is digitising the interface between the surgeon and the patient...

January 5, 2023 | Thursday | News